Yue Hua H - OmicsDI

Show results for

Unknown (68)
Proteomics (10)
Transcriptomics (2)
Metabolomics (2)
Genomics (1)

Organisms

Homo sapiens (5)
Mus musculus (3)
Brassica oleracea (1)
Severe acute respiratory syndrome coronavirus 2 (1)
Escherichia coli (1)
Campylobacter jejuni subsp. jejuni NCTC 11168 = ATCC 700819 (1)
Escherichia coli HT115 (1)
Candidatus Glomeribacter (1)
Linnemannia elongata AG-77 (1)
Anthozoa (1)
Serratia phage JS26 (1)
Acinetobacter baumannii 1656-2 (1)
Cupriavidus pinatubonensis JMP134 (1)
Serratia ureilytica (1)
Eimeria necatrix (1)
Hoilungia hongkongensis (1)
Soa (1)
Acinetobacter nosocomialis (1)
Synechocystis sp. PCC 6803 substr. GT-S (1)
NEWT:1001077 (1)
Amphimedon (1)
Triplophysa siluroides (1)
Phyllorhiza punctata (1)
Beauveria bassiana (1)
Asfarviridae (1)
Tachaea chinensis (1)
Breviatea (1)
Tibellus oblongus (1)
Alteromonas macleodii ATCC 27126 (1)
Arcobacter (1)

Repository

iProX (8)
biostudies-arrayexpress (2)
MetaboLights (2)
EGA (1)
MassIVE (1)
pride (1)

Tissue

Cell line cell (1)
Cell culture (1)

Disease

Malignant neoplasm of ovary (1)

Technology Type

Mass spectrometry (2)
Mass Spectrometry (1)
Shotgun proteomics (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (2)
Q Exactive HF-X (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2022 (3)
2014 (1)
2005 (1)
2025 (1)
2024 (1)
2020 (1)
2019 (1)
2023 (1)
2018 (1)

CHEBI ID

CHEBI:137604 (1)
CHEBI:66862 (1)
CHEBI:134487 (1)
CHEBI:85851 (1)
CHEBI:65302 (1)
CHEBI:28328 (1)
CHEBI:16374 (1)
CHEBI:134451 (1)
CHEBI:65294 (1)
CHEBI:18067 (1)
CHEBI:16217 (1)
CHEBI:75095 (1)
CHEBI:1606 (1)
CHEBI:18300 (1)
CHEBI:66848 (1)
CHEBI:15682 (1)
CHEBI:16973 (1)
CHEBI:30860 (1)
CHEBI:17650 (1)
CHEBI:15698 (1)
CHEBI:18287 (1)
CHEBI:32805 (1)
CHEBI:17164 (1)
CHEBI:16962 (1)
CHEBI:16827 (1)
CHEBI:17252 (1)
CHEBI:16852 (1)
CHEBI:17405 (1)
CHEBI:4630 (1)
CHEBI:22652 (1)

Metabolite Name

Phosphatidylethanolamine(38:4) (1)
Phosphatidylethanolamine(36:4) (1)
Phosphatidylethanolamine(36:1) (1)
Phosphatidylcholine(40:8) (1)
Phosphatidylcholine(40:4) (1)
Phosphatidylcholine(38:6) (1)
Phosphatidylcholine(38:5) (1)
Phosphatidylcholine(36:3) (1)
Phosphatidylcholine(36:2) (1)
Phosphatidylcholine(35:2) (1)
Phosphatidylcholine(34:1) (1)
Phosphatidylcholine(34:2) (1)
Phosphatidylcholine(33:5) (1)
Phosphatidylcholine(32:2) (1)
Phosphatidylcholine(32:0) (1)
Phosphatidylcholine(31:0) (1)
Phosphatidylcholine(33:1) (1)
Phosphatidylcholine(30:0) (1)
Phosphatidylcholine(28:0) (1)
Dopaquinone (1)
3,4-Dihydroxyphenylpropionic acid (1)
Phosphatidylcholine(40:6) (1)
Phosphatidylcholine(38:3) (1)
Phosphatidylcholine(38:4) (1)
Phosphatidylcholine(36:1) (1)
Phosphatidylcholine(36:5) (1)
Phosphatidylcholine(32:1) (1)
Phosphatidylcholine(30:1) (1)
Tyrosol (1)
D-Glucono-1,5-lactone (1)

Study type

Transcription profiling by SAGE (1)
RNA-seq of coding RNA (1)

Release Date

2020 (19)
2022 (12)
2025 (9)
2021 (9)
2024 (5)
2023 (4)
2018 (3)
2014 (2)
2019 (2)
2017 (2)
2016 (2)
2005 (1)

Lab affiliation

Institute of Nuclear-Agricultural Sciences, Zhejiang University (1)

Previous page
1 / 9
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 9
Next page

Sort by:

Relevance

Page size

Global Landscapes of the Na⁺/H⁺ Antiporter (NHX) Family Members Uncover their Potential Roles in Regulating the Rapeseed Resistance to Salt Stress.

Not available

S-EPMC7279160 | biostudies-literature

Fatty acid oxidation protects cancer cells from apoptosis through increasing mitochondrial membrane lipids

Overcoming resistance to chemotherapies remains a major unmet need for cancers such as triple negative breast cancer (TNBC). Therefore, mechanistic studies to provide insight for drug development are urgently needed to overcome TNBC therapy resistance. Recently, an important role of fatty acid β-...

2022-05-31 | MTBLS4709 | MetaboLights

Ovarian cancer cell line LC-MS-MS

A2780-DR cells are cisplatin resistance compared to A2780. H19 knockdown in A2780-DR cells resulted in recovery of cisplatin sensitivity in vitro and in vivo. To demonstrate how H19 contributes to cisplatin-resistance in ovarian cancer, proteomic analysis was carried out on A2780, A2780-DR, A2780-DR...

ORGANISM(S): Homo sapiens (Human)

2018-10-25 | PXD003252 | Pride